It is critical to establish that the treatment is safe...

It is critical to establish that the treatment is safe @Outlander2

Drawing from the ASCO Gastrointestinal Cancer symposium poster presentation, we note that treatment with CF33-hNIS monotherapy in patients with GI cancers is well tolerated. In fact the most common adverse events include flu-like symptoms such as fever and fatigue. In one way it is unsurprising that an oncolytic virus should have such benign side effects. In the case of Vaxinia, its flu-like symptoms. In the case of another well documented oncolytic virus of more natural origins, its fever and an itch.

Reference is made to the article Measles Virus as Cancer Therapy by Mike May PhD published 20 September 2023. The author discusses a German investigation into the use of the measles virus as a therapeutic cancer treatment. The research team are looking at improved production strategies to harness the utility of measles to selectively replicate in and kill cancer cells.

Some might remember Professor Yuman Fong talking about his light-bulb moment when he realised, let nature do its job to design a cancer killing virus that will kill all types of cancer cells. The answer to a universal cancer treatment was always there but hidden in plain sight. It just took Professor Fong to scratch an itch.